acitretin has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamonal, ACC; Gamonal, SBL; Marques, NCV; Pereira, HMB | 1 |
| Aksan, B; Arica, DA; Arıca, İE; Aydemir, B; Baykal Selcuk, LB; Dere, G; Etgu, F; Gündogdu, M; Kulakli, S; Oguz, ID; Oguzer, SE; Onder, S; Saral, Y; Yayli, S | 1 |
| Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B | 1 |
3 other study(ies) available for acitretin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.
Topics: Acitretin; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Pityriasis Rubra Pilaris; RNA, Messenger; Ustekinumab | 2022 |
Incidence and Prognosis of COVID-19 in Patients with Psoriasis: A Multicenter Prospective Study from the Eastern Black Sea Region of Turkey.
Topics: Acitretin; Black Sea; COVID-19; Hospitalization; Humans; Incidence; Prognosis; Prospective Studies; Psoriasis; Turkey | 2022 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy | 2021 |